METHYL 4-AZA-5ALPHA-ANDROSTA-1-EN-3-ONE-17BETA-CARBOXYLATE CAS 103335-41-7

Khoom Piav Qhia:

Khoom Lub Npe: METHYL 4-AZA-5ALPHA-ANDROSTA-1-EN-3-ONE-17BETA-CARBOXYLATE CAS TSIS TAU: 103335-41-7

Lub ntsiab lus:

3-Oxo-4-aza-5Alpha-Alphandrost-1-ene-17Beta-carboxylic Acid Methyl Ester;

(4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -methyl 4a, 6a-dimethyl-2-oxo-2,4a, 4b, 5,6,6a, 7,8,9,9a, 9b, 10 , 11,11a-tetradecahydro-1H-indeno [5,4-f] quinoline-7-carboxylate;

Methyl 3-oxo-4-aza-5a-androst-1-ene-17beta-carboxylate;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Tawm-Dawb Khoom

Kev Ntsuas: ≥99.0%

Ceev: 1.114g/cm3

Kub Point: 478.615 ℃ ntawm 760 mmHg

Melting Point: 280-282 ℃ (dec.)

Flash Point: 243.258 ℃

Refractive Index: 1.525

Vapor Siab: 0mmHg ntawm 25 ℃

Finasteride thiab Dutasteride tsis huv. Ib nrab hauv kev sib xyaw ntawm Finasteride thiab Dutasteride, 5α-reductase inhibitors siv rau kev kho mob benign prostatic hyperplasia pob txuv, seborrhea, poj niam hirsutism, prostatitis, thiab prostatic carcinoma thiab lwm yam kev cuam tshuam txog hyperandrogenetic. Finasteride tsis huv.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: methyl 4-aza-5alpha-androsta-1-en-3-one-17beta-carboxylate cas 103335-41-7, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: 4-Aza-5a-androstan-1-ene-3-one-17b-carboxylic Acid CAS 104239-97-6
• Tom ntej: 3-Oxo-4-aza-5-alpha-androstane-17-beta-carboxylic Acid CAS 103335-55-3